Veru (VERU) Set to Announce Quarterly Earnings on Wednesday

Veru (NASDAQ:VERU) is scheduled to be announcing its earnings results before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Veru (NASDAQ:VERU) last released its earnings results on Monday, April 1st. The company reported ($0.09) EPS for the quarter. The firm had revenue of $2.14 million for the quarter. Veru had a negative return on equity of 257.92% and a negative net margin of 405.04%. On average, analysts expect Veru to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Veru Price Performance

VERU stock traded up $0.05 during trading on Monday, hitting $1.68. 396,478 shares of the company traded hands, compared to its average volume of 2,385,090. The stock’s 50-day simple moving average is $0.93 and its 200 day simple moving average is $0.79. The company has a market cap of $245.19 million, a PE ratio of -2.17 and a beta of -0.47. Veru has a 1 year low of $0.36 and a 1 year high of $1.92.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Raymond James assumed coverage on Veru in a research report on Thursday, March 28th. They set an “outperform” rating and a $3.00 price target for the company. Oppenheimer reiterated an “outperform” rating and set a $5.00 price target (down from $7.00) on shares of Veru in a research report on Monday, April 15th. Finally, HC Wainwright upped their target price on Veru from $2.00 to $3.00 and gave the stock a “buy” rating in a research note on Monday.

About Veru

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.